TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05891418

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Two informational emails with plan information
Description: Informational emails about the benefits of Cost-Sharing Reduction Silver plans.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Standard notice of eligibility determination
Description: No extra outreach during intervention period.
Study: NCT06315764

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Reflexology
Description: Following four weeks of treatment (post-1) and additional four weeks of treatment (post-2) the post evaluation was used (post-2).Before and after the foot reflexology, blood pressure was checked twice. Around 20 minutes is spent on foot reflexology .~Each patient in this study did 20 minutes of peddler aerobic training, with the first 5 minutes serving as a warm-up with intensity set at 60 - 65 percent of maximal heart rate, followed by another 10 minutes of peddler training with intensity gradually increased up to 70 - 75 percent, and the last 5 minutes serving as a cooling down with intensity set at 60 - 65 percent of maximal heart rate. After the warm-up and at the end of each training phase, the participants' heart rates were monitored. Finally, if the individual experienced pain, fainting, or shortness of breath, the training was promptly terminated as well as reflexology three times each week for eight weeks

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Reflexology
Description: Following four weeks of treatment (post-1) and additional four weeks of treatment (post-2) the post evaluation was used (post-2).Before and after the foot reflexology, blood pressure was checked twice. Around 20 minutes is spent on foot reflexology .~Each patient in this study did 20 minutes of peddler aerobic training, with the first 5 minutes serving as a warm-up with intensity set at 60 - 65 percent of maximal heart rate, followed by another 10 minutes of peddler training with intensity gradually increased up to 70 - 75 percent, and the last 5 minutes serving as a cooling down with intensity set at 60 - 65 percent of maximal heart rate. After the warm-up and at the end of each training phase, the participants' heart rates were monitored. Finally, if the individual experienced pain, fainting, or shortness of breath, the training was promptly terminated as well as reflexology three times each week for eight weeks
Study: NCT05571995

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: TRIMOSH
Description: TRIMOSH will improve the knowledge, attitude and practice on occupational and health
Study: NCT05119413

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: New trio de Kligman
Description: Once daily application in addition to the same sunscreen

Intervention type: DRUG
Group type: OTHER
Intervention: Trio Kligman
Description: Once daily application in addition to the same sunscreen
Study: NCT05158439

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: AlloRx
Description: cultured allogeneic adult umbilical cord derived mesenchymal stem cells
Study: NCT04961320

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Occupational Therapy
Description: Participate in OT session

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Complete questionnaires
Study: NCT05285826

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: 9vHPV Vaccine
Description: 9-valent human papillomavirus (Types 6, 11, 16, 18, 31, 33, 45, 52, 58) L1 virus-like particle vaccine administered as a 0.5-mL IM injection

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Sterile saline solution administered as a 0.5 mL IM injection
Study: NCT04789577

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: FLU-Q-PAN H7N9 Formulation 1
Description: Participants received two doses of the FLU-Q-PAN H7N9 Formulation 1 vaccine by intramuscular injection in the non-dominant arm.

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: FLU-Q-PAN H7N9 Formulation 1
Description: Participants received two doses of the FLU-Q-PAN H7N9 Formulation 1 vaccine by intramuscular injection in the non-dominant arm.

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: FLU-Q-PAN H7N9 Formulation 2
Description: Participants received two doses of the FLU-Q-PAN H7N9 Formulation 2 vaccine by intramuscular injection in the non-dominant arm.

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: FLU-Q-PAN H7N9 Formulation 2
Description: Participants received two doses of the FLU-Q-PAN H7N9 Formulation 2 vaccine by intramuscular injection in the non-dominant arm.

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: FLU-Q-PAN H7N9 Formulation 3
Description: Participants received two doses of the FLU-Q-PAN H7N9 Formulation 3 vaccine by intramuscular injection in the non-dominant arm.

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: FLU-Q-PAN H7N9 Formulation 3
Description: Participants received two doses of the FLU-Q-PAN H7N9 Formulation 3 vaccine by intramuscular injection in the non-dominant arm.

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: AS03B
Description: Participants received two doses of the AS03B adjuvant by intramuscular injection in the non-dominant arm.

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: AS03B
Description: Participants received two doses of the AS03B adjuvant by intramuscular injection in the non-dominant arm.

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: AS03B
Description: Participants received two doses of the AS03B adjuvant by intramuscular injection in the non-dominant arm.

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: AS03A
Description: Participants received two doses of the AS03A adjuvant by intramuscular injection in the non-dominant arm.

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: AS03A
Description: Participants received two doses of the AS03A adjuvant by intramuscular injection in the non-dominant arm.

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: AS03A
Description: Participants received two doses of the AS03A adjuvant by intramuscular injection in the non-dominant arm.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Participants received two doses of Placebo by intramuscular injection in the non-dominant arm.
Study: NCT06382389

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EMONO
Description: Exposure of Emono via facial mask

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Medical air
Description: exposure to Medical Air
Study: NCT05092048

Intervention type: OTHER
Intervention: questionnaire
Description: PHQ-9 and GAD-7 questionnaire
Study: NCT05167331

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nitrous Oxide inhalation
Description: use of Nitrous Oxide inhalation on children's anxiety during a dental treatment

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Dispositif de RV - HYPNO VR
Description: use of Virtual Reality on children's anxiety during a dental treatment
Study: NCT01239524

Intervention type: PROCEDURE
Group type: OTHER
Intervention: denervation of thoracodorsal nerve or saving the nerve

Intervention type: PROCEDURE
Group type: OTHER
Intervention: denervation of thoracodorsal nerve or saving the nerve
Study: NCT05475626

Intervention type: PROCEDURE
Intervention: Arthroereisis-
Description: Surgical options include soft tissue procedures, realignment osteotomies and non-fusion motion-limiting techniques.
Study: NCT04641702

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atropine challenge
Description: Atropine challenge. After baseline FLIP, subjects will be administered 15 mcg/kg of intravenous atropine. Two minutes after administration, FLIP will be repeated.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Esophageal muscle biopsy
Description: Esophageal muscle biopsy. During standard-of-care Heller myotomy or per-oral endoscopic myotomy, 5mm of lower esophageal sphincter and distal esophageal circular muscle will be collected via biopsy forceps.
Study: NCT06009289

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Light therapy
Description: One hour of exposure to bright light, either by being outdoors or with a phototherapy lamp if indoor

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Light therapy
Description: One hour of exposure to bright light, either by being outdoors or with a phototherapy lamp if indoor
Study: NCT05863793

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Acupuncture
Description: The obligatory acupoints include Zhongwan (CV12), bilateral Weiwanxiashu (EX-B3), bilateral Ganshu (BL18), bilateral Pishu (BL20), bilateral Shenshu (BL23), bilateral Zusanli (ST36), bilateral Yanglingquan (GB34), bilateral Sanyinjiao (SP6), bilateral Taixi (KI3), and Bafeng (EX-LE10). Additional acupoints Baxie (EX-UE9) will be added when patients' symptoms appear not only in the lower limbs but also in the upper limbs. After skin disinfection, disposable, stainless steel acupuncture needles will be inserted into the skin of acupoint (approximately 10-20 mm depth), and then manipulations of twirling, lifting, and thrusting will be performed on all needles for at least 10 s to reach De qi (a compositional sensation including soreness, numbness, distention, and heaviness), which is believed to be an essential component for acupuncture efficacy. Needles will be retained in these acupoints for 20 min.

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham Acupuncture
Description: Patients in the SA group will receive sham acupuncture. The procedure and duration of treatment in the SA group will be identical in the MA group except the needles are blunt tip and there will be no skin penetration and needle manipulation for De qi.
Study: NCT05436015

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual nature-based intervention
Description: Virtual nature-based intervention is video with Finnish naturepictures and naturesounds shown from a 75 vertical screen monitor
Study: NCT05026268

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: intracorporeal anastomosis
Description: intracorporeal stapled side-to-side isoperistaltic anastomosis
Study: NCT06142734

Intervention type: PROCEDURE
Group type: OTHER
Intervention: pyeloplasty
Description: * For laparoscopic pyeloplasty:~* Anaesthesia: general~* Position: a 45-degree lateral decubitus position with the concerned side up. Patient is secured to the operating table. Pneumoperitoneum is adopted through a camera port lateral to the umbilicus~* extra operating ports are created at subcostal and at spinoumbilial line.~* the UPJ is transperitoneally accessed by incising the white line of Toldt and the ipsilateral colon is reflected and the proximal ureter and the pelvis are identified an mobilized~* then Anderson- Hynes pyeloplasty is carried out with insertion of nephroureterostomy or pyeloureterostomy tube.

Intervention type: PROCEDURE
Group type: OTHER
Intervention: pyeloplasty
Description: * For laparoscopic pyeloplasty:~* Anaesthesia: general~* Position: a 45-degree lateral decubitus position with the concerned side up. Patient is secured to the operating table. Pneumoperitoneum is adopted through a camera port lateral to the umbilicus~* extra operating ports are created at subcostal and at spinoumbilial line.~* the UPJ is transperitoneally accessed by incising the white line of Toldt and the ipsilateral colon is reflected and the proximal ureter and the pelvis are identified an mobilized~* then Anderson- Hynes pyeloplasty is carried out with insertion of nephroureterostomy or pyeloureterostomy tube.
Study: NCT04749355

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BST-236
Description: BST-236 is a conjugate of cytarabine and asparagine, provided as a sterile lyophilized powder for IV administration
Study: NCT05047978

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Cow's milk protein infant formula
Description: A routine cow's milk-based infant formula

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Partially hydrolyzed protein infant formula
Description: A partially hydrolyzed cow's milk protein (PHP) infant formula
Study: NCT04979247

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oliceridine
Description: Near the end of surgery, patients will be given ≤1.5 mg of oliceridine as a bolus. Postoperatively, patient-controlled analgesia (PCA) will be started with no background infusion, demand doses of 0.35 mg, with a 6 minute lock-out. Additional boluses (≤1 mg) of oliceridine will be given as deemed necessary (based on NRS score and clinical assessment of the patient) as soon as 15 minutes after the initial 1.5 mg loading dose. In addition to supplemental 1 mg bolus doses, the PCA demand dose can be increased to a maximum of 0.5 mg oliceridine.
Study: NCT06201546

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: TAP block group
Description: TAP block will be administrated after LSG. In TAP block local anesthetic(%0,25 bupivacaine-20ml)will be administrated the between the transversus abdominis muscle and the internal abdominal muscle fascia.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: m-TAPA block group
Description: m-TAPA block will be administrated after LSG. In m-TAPA block local anesthetic (0.25% bupivacaine-20ml) will be administrated between the transversus abdominis muscle and the internal abdominal muscle fascia under the costochondrial region
Study: NCT06339294

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Clotrimazole Cream
Description: Single time application of clotrimazole ointment was done after aural toilet in external auditory canal via IV catheter

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Povidone-Iodine
Description: Gelfoam soaked pyodine solution was placed in external auditory canal after aural toilet
Study: NCT05771584

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AST-301
Description: 100 μg

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AST-301
Description: 100 μg

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: rhuGM-CSF
Description: 100 μg

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: rhuGM-CSF
Description: 100 μg
Study: NCT06201208

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: The ST-Facilitation Psychoeducation Program
Description: One of the important roles of the psychiatric nurse, who helps healthy/sick individuals and their families to improve their mental health, prevent and cope with diseases, is their educational role. The psychiatric nurse determines the psychosocial care needs of the patient and his family and plans, implements and evaluates psychoeducational interventions, which are an evidence-based practice, to meet these needs.~Psychiatric nurses can benefit from existing programs when developing a psychoeducation program, or they can be advised to create programs that include educational and psychosocial goals based on theory specific to the problems of the relevant population. The theoretical basis is of great importance when planning a psychoeducation program. In this study, the psychoeducation program was based on the Self-Transcendence Theory of Pamela G. Reed, a psychiatric nurse.
Study: NCT06034678

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Food Allergy Mastery Program
Description: Food Allergy Mastery Program sessions will be delivered by masters-level counselors as 6 45-minute biweekly telehealth or in-person sessions over a period of 3 months. Session 1 will include both youth and caregiver, Session 2 will be a group session with 5-6 youth, Session 3 will include both youth and caregiver, Sessions 4-5 will be individual youth sessions, and Session 6 will include both youth and caregiver. Sessions will incorporate a variety of formats, each based on the needs of the session content.
Study: NCT05808270

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Nutrition care process
Description: According to the randomization and simple blinding, there will be 2 study groups in which group 1 will be operated on Nutrition care process and group 2 with Conventional nutritional intervention.~* The Nutrition Care Process is a standardized model intended to guide RDNs in providing high quality nutrition care. The NCP consists of four distinct, interrelated steps: Nutrition Assessment, Diagnosis, Intervention, and Monitoring/Evaluation (AND, 2023).~* In the case of Conventional nutritional intervention, we will base ourselves on the application of a habitual nutritional clinical history, where information will be obtained on the reasons for consultation and the specific needs of the patient to carry out an intervention based on their priorities.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Nutrition care process
Description: According to the randomization and simple blinding, there will be 2 study groups in which group 1 will be operated on Nutrition care process and group 2 with Conventional nutritional intervention.~* The Nutrition Care Process is a standardized model intended to guide RDNs in providing high quality nutrition care. The NCP consists of four distinct, interrelated steps: Nutrition Assessment, Diagnosis, Intervention, and Monitoring/Evaluation (AND, 2023).~* In the case of Conventional nutritional intervention, we will base ourselves on the application of a habitual nutritional clinical history, where information will be obtained on the reasons for consultation and the specific needs of the patient to carry out an intervention based on their priorities.
Study: NCT04878302

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Combination of Comprehensive Behavioral Intervention for Tics (CBIT) and Evidence-based interventions for co-occurring diagnoses (i.e., Cognitive Behavioral Therapy, Behavioral Parent Training)
Description: Families assigned to the immediate treatment group will receive the telehealth-based Taming Tics Together protocol(created using well-established, evidence-based treatment protocols), which includes group (parent/caregiver-only, child/teen-only) and individualized one-to-one sessions to address tics and co-occurring diagnoses.
Study: NCT05332717

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Melatonin 5 mg
Description: Participants will be taking one 5 mg tablet of Melatonin 30 minutes before bedtime nightly, for 6 weeks following their knee replacement surgeries.

Intervention type: DIETARY_SUPPLEMENT
Group type: SHAM_COMPARATOR
Intervention: Placebo (Vitamin C)
Description: Participants will be taking one placebo tablet 30 minutes before bedtime nightly, for 6 weeks following their knee replacement surgeries.
Study: NCT05080725

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: TelePEPP intervention
Description: TelePEPP sessions will be conducted twice per week by a Speech Language Pathologist and/or graduate student clinician, on the study team. This clinician will deliver the intervention from the NYU Voice Center using the web conferencing software Webex (institutional license) on a Dell desktop computer with a 3.1 GHz intel core processor and high definition camera. Each exercise set will include 40 repetitions (10 reps of effortful swallows, tongue hold swallows, effortful pitch glides and maximal posterior tongue presses). All exercises are widely-adopted by clinicians as standard of care exercises. The number of sets will be gradually increased as tolerance builds \[2 sets in week 1, 3 sets in week 2, 4 sets in weeks 3+\].
Study: NCT05962827

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: lipoprotein (a)
Description: dosage of lipoprotein (a)
Study: NCT06216405

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Colonoscopy
Description: Colonoscopy

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Colonoscopy
Description: Colonoscopy
Study: NCT06396299

Intervention type: OTHER
Intervention: No intervention
Description: No intervention
Study: NCT05837546

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Animal-assisted intervention
Description: presence of a dog, contact between dog and participant

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Factice dog intervention
Description: presence of a factice dog, contact between factice dog and participant

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Plant intervention
Description: presence of a plant, contact between plant and participant
Study: NCT06537050

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: JX2105
Description: Oral capsule

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Oral capsule
Study: NCT06367777

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: cervical a-tsDCS
Description: Anodal transcutaneous spinal direct current stimulation (a-tsDCS)

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: thoracic a-tsDCS
Description: Anodal transcutaneous spinal direct current stimulation (a-tsDCS)

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: sham tsDCS
Description: Sham transcutaneous spinal direct current stimulation (s-tsDCS)
Study: NCT06157619

Intervention type: PROCEDURE
Intervention: Oocyte Vitrification /Warming
Description: In Vitro matured oocytes will be randomly assigned to any of the two Vitrification protocols

Intervention type: PROCEDURE
Intervention: Oocyte Vitrification /Warming
Description: In Vitro matured oocytes will be randomly assigned to any of the two Vitrification protocols
Study: NCT04966078

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: liposuction
Description: suction-assisted liposuction

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: surgical excision
Description: periareolar surgical excision
Study: NCT04744805

Intervention type: OTHER
Intervention: face mask or not
Description: long term face mask wear

Intervention type: OTHER
Intervention: face mask or not
Description: long term face mask wear
Study: NCT05458440

Intervention type: OTHER
Group type: OTHER
Intervention: Generation of a biobank allowing the cryopreservation of leucocytes from COVID19 convalescent donors
Description: The investigators aim to demonstrate that it is possible to implement a biobank of leucocytes from convalescent donors that could be used as raw material to generate anti-SARS COV-2 viral specific T cells. The protocol will be explained during hospitalisation for each donor. If they agree, they will be included before they leave hospital. Few weeks later, if they have no exclusion criteria, they will consult in the hemapheresis department of the Nancy University hospital. After medical exams, a whole blood bag and blood samples will be taken with the aim to establish a bank of cryopreserved human leucocytes as a raw material for the generation of a T-Lymphocyte immunotherapy.